BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31599967)

  • 1. In vivo safety assessment of Lactobacillus fermentum strains, evaluation of their cholesterol-lowering ability and intestinal microbial modulation.
    Thumu SCR; Halami PM
    J Sci Food Agric; 2020 Jan; 100(2):705-713. PubMed ID: 31599967
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zafar H; Ain NU; Alshammari A; Alghamdi S; Raja H; Ali A; Siddique A; Tahir SD; Akbar S; Arif M; Alharbi M; Rahman A
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet.
    Xie N; Cui Y; Yin YN; Zhao X; Yang JW; Wang ZG; Fu N; Tang Y; Wang XH; Liu XW; Wang CL; Lu FG
    BMC Complement Altern Med; 2011 Jul; 11():53. PubMed ID: 21722398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocholesterolemic Effect of Potential Probiotic Lactobacillus fermentum Strains Isolated from Traditional Fermented Foods in Wistar Rats.
    Thakkar PN; Patel A; Modi HA; Prajapati JB
    Probiotics Antimicrob Proteins; 2020 Sep; 12(3):1002-1011. PubMed ID: 31760594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats.
    Cavalcante RGS; de Albuquerque TMR; de Luna Freire MO; Ferreira GAH; Carneiro Dos Santos LA; Magnani M; Cruz JC; Braga VA; de Souza EL; de Brito Alves JL
    Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1408-1417. PubMed ID: 31640890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Probiotic Lactobacillus fermentum CCM 7421 Administration with Alginite in Dogs.
    Strompfová V; Kubašová I; Farbáková J; Maďari A; Gancarčíková S; Mudroňová D; Lauková A
    Probiotics Antimicrob Proteins; 2018 Sep; 10(3):577-588. PubMed ID: 29256151
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Linninge C; Xu J; Bahl MI; Ahrné S; Molin G
    Benef Microbes; 2019 Apr; 10(4):413-424. PubMed ID: 30957532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of Lactobacillus fermentum post-weaning improves the lipid profile and autonomic dysfunction in rat offspring exposed to maternal dyslipidemia.
    de Oliveira Y; Cavalcante RGS; Cavalcanti Neto MP; Magnani M; Braga VA; de Souza EL; de Brito Alves JL
    Food Funct; 2020 Jun; 11(6):5581-5594. PubMed ID: 32524104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Assessment of Potential Probiotic Lactobacillus fermentum MTCC-5898 in Murine Model after Repetitive Dose for 28 Days (Sub-Acute Exposure).
    Samtiya M; Bhat MI; Gupta T; Kapila S; Kapila R
    Probiotics Antimicrob Proteins; 2020 Mar; 12(1):259-270. PubMed ID: 30847835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus fermentum NCIMB 5221 and NCIMB 2797 as cholesterol-lowering probiotic biotherapeutics: in vitro analysis.
    Tomaro-Duchesneau C; Saha S; Malhotra M; Jones ML; Rodes L; Prakash S
    Benef Microbes; 2015; 6(6):861-9. PubMed ID: 26322545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats.
    Tomaro-Duchesneau C; Saha S; Malhotra M; Jones ML; Labbé A; Rodes L; Kahouli I; Prakash S
    Appl Microbiol Biotechnol; 2014 Jan; 98(1):115-26. PubMed ID: 24121931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic Characterization of Cholesterol-Lowering Lactobacillus fermentum MJM60397.
    Palaniyandi SA; Damodharan K; Suh JW; Yang SH
    Probiotics Antimicrob Proteins; 2020 Sep; 12(3):1161-1172. PubMed ID: 31432401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic attributes of Lactobacillus fermentum isolated from human feces and dairy products.
    Archer AC; Halami PM
    Appl Microbiol Biotechnol; 2015 Oct; 99(19):8113-23. PubMed ID: 26004804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially Probiotic Limosilactobacillus fermentum Fruit-Derived Strains Alleviate Cardiometabolic Disorders and Gut Microbiota Impairment in Male Rats Fed a High-Fat Diet.
    de Araújo Henriques Ferreira G; Magnani M; Cabral L; Brandão LR; Noronha MF; de Campos Cruz J; de Souza EL; de Brito Alves JL
    Probiotics Antimicrob Proteins; 2022 Apr; 14(2):349-359. PubMed ID: 35066820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiated In Vitro Probiotic Activities of Lactobacillus fermentum LfQi6 Biofilm Biomass Versus Planktonic Culture.
    Berkes E; Liao YH; Neef D; Grandalski M; Monsul N
    Probiotics Antimicrob Proteins; 2020 Sep; 12(3):1097-1114. PubMed ID: 31828607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats.
    Cruz Neto JPR; de Oliveira AM; de Oliveira KÁR; Sampaio KB; da Veiga Dutra ML; de Luna Freire MO; de Souza EL; de Brito Alves JL
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):752-762. PubMed ID: 37119497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yersinia enterocolitica and Lactobacillus fermentum induces differential cellular and behavioral responses during diclofenac biotransformation in rat gut.
    Ahlawat S; Shankar A; Vandna ; Mohan H; Sharma KK
    Toxicol Appl Pharmacol; 2021 Nov; 431():115741. PubMed ID: 34619158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota.
    Lye HS; Kato T; Low WY; Taylor TD; Prakash T; Lew LC; Ohno H; Liong MT
    J Biotechnol; 2017 Nov; 262():75-83. PubMed ID: 28935567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption of Probiotic Lactobacillus fermentum MTCC: 5898-Fermented Milk Attenuates Dyslipidemia, Oxidative Stress, and Inflammation in Male Rats Fed on Cholesterol-Enriched Diet.
    Yadav R; Khan SH; Mada SB; Meena S; Kapila R; Kapila S
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):509-518. PubMed ID: 29754388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antimicrobial synbiotics using potentially-probiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum.
    Likotrafiti E; Tuohy KM; Gibson GR; Rastall RA
    Anaerobe; 2013 Apr; 20():5-13. PubMed ID: 23354005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.